India: Novartis Hearing Postponed To February 30/11/2011 by Intellectual Property Watch Leave a Comment The Supreme Court in New Delhi has postponed the Novartis v. Union of India hearing. The case will now be heard on 28 February 2012.
IP, Trade And Public Health Leaders Turn A Page In History Together 24/11/2011 by William New, Intellectual Property Watch 2 Comments The importance of multilateralism, continuing global public health gains with sufficient funding, and finding a balance between the worlds of trade, intellectual property and public health were among the top issues raised during the a daylong high-level meeting at the World Trade Organization.
Doha+10: MSF Asks, What’s Next For TRIPS And Health? 22/11/2011 by Rachel Marusak Hermann, Intellectual Property Watch Leave a Comment For Médecins Sans Frontières (MSF, or Doctors Without Borders), the 10th anniversary of the Doha Declaration on Trade-Related Aspects of Intellectual Property Rights (TRIPS) and Public Health marks an opportunity to look forward.
US, China Hold High-Level Talks On IP Policy 21/11/2011 by William New, Intellectual Property Watch Leave a Comment The United States and China made notable progress on a range of intellectual property policy issues in cabinet-level meetings ending today, according to the US government.
10 Years Of TRIPS And Public Health: An Anniversary To Celebrate? 21/11/2011 by Rachel Marusak Hermann, Intellectual Property Watch 4 Comments It has been 10 years since the World Trade Organization adopted the Doha Declaration on TRIPS and Public Health. The declaration highlighting the public health aspects of the WTO Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreed at the 2001 WTO ministerial conference in Doha, Qatar was considered a milestone in ensuring greater access to medicines for all.
WIPO Development Committee Completes Work; Creates Technical Cooperation Review Group 18/11/2011 by William New, Intellectual Property Watch 1 Comment The World Intellectual Property Organization Committee on Development and Intellectual Property (CDIP) successfully completed its eighth session tonight, making progress on a range of projects and agreeing to set up an ad hoc working group to examine an external report on the UN agency’s global provision of technical assistance.
Debate At WIPO Over Process For Technical Assistance Review 18/11/2011 by William New, Intellectual Property Watch 1 Comment Members of the World Intellectual Property Organization this week are slogging through a series of documents related to intellectual property and development. But one document, an external report on WIPO’s provision of technical cooperation assistance, has given way to a substantive discussion about how to fully address the report’s findings of the need for improvement at the UN agency.
Barrage Of Doubts Voiced On US Internet Piracy Bill 16/11/2011 by William New, Intellectual Property Watch 3 Comments An international outcry from open internet proponents has emerged over draft US legislation, HR 3261, the Stop Online Piracy Act (SOPA), on the eve of a hearing on the bill. International critics say the bill would put the United States on the same ground as China with regards to internet filtering, undermining the US argument for internet freedom.
Global Action To Open Generic Competition For Key AIDS Drug 16/11/2011 by Intellectual Property Watch 1 Comment Public health advocates in a dozen countries worldwide have launched a coordinated campaign to bring about generic competition on a key medicine for HIV/AIDS, currently under patent by a pharmaceutical producer.
WIPO: IP Policy Moves To Forefront Of Global Innovation 15/11/2011 by Rachel Marusak Hermann, Intellectual Property Watch Leave a Comment The World Intellectual Property Organization has released its first report in what is expected to be a series of publications seeking to explain, clarify and contribute to policy relating to intellectual property. Its debut report, WIPO presented figures that show a growing global demand for patents, a soaring increase in licensing and royalty fees revenues, and an increase in low and middle-income economies’ share of global spending on research and development.